IMNM logo

Immunome, Inc. (IMNM) Return On Equity

Annual ROE:

-194.63%-38.18%(-24.40%)
December 31, 2024

Summary

  • As of today, IMNM annual return on equity is -194.63%, with the most recent change of -38.18% (-24.40%) on December 31, 2024.
  • During the last 3 years, IMNM annual ROE has fallen by -139.43% (-252.59%).
  • IMNM annual ROE is now -725.42% below its all-time high of 31.12%, reached on December 31, 2018.

Performance

IMNM ROE Chart

Add series to chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
series name
Suggested series

Highlights

Range

Earnings dates

OtherIMNMprofitability metrics

Quarterly ROE:

-86.60%-4.07%(-4.93%)
June 30, 2025

Summary

  • As of today, IMNM quarterly return on equity is -86.60%, with the most recent change of -4.07% (-4.93%) on June 30, 2025.
  • Over the past year, IMNM quarterly ROE has increased by +108.00% (+55.50%).
  • IMNM quarterly ROE is now -241.48% below its all-time high of 61.21%, reached on June 30, 2020.

Performance

IMNM Quarterly ROE Chart

Add series to chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
series name
Suggested series

Highlights

Range

Earnings dates

OtherIMNMprofitability metrics

ROE Formula

ROE =  Net Income
Shareholders Equity
✕ 100%

IMNM ROE Trends

PeriodPeriodAnnualAnnualQuarterlyQuarterly
1Y1 Year-24.4%+55.5%
3Y3 Years-252.6%-11.0%
5Y5 Years-764.0%-241.5%

IMNM ROE Highs & Lows

PeriodPeriodAnnual vs HighAnnual vs HighAnnual vs LowAnnual vs LowQuarter. vs HighQuarter. vs HighQuarter. vs LowQuarter. vs Low
3Y3-Year-252.6%at low-4.9%+73.1%
5Y5-Year-764.0%+68.8%-258.6%+97.8%
All-TimeAll-Time-725.4%+68.8%-241.5%+97.8%

IMNM ROE History

DateAnnualQuarterly
Jun 2025
-
-86.60%(-4.9%)
Mar 2025
-
-82.53%(+40.5%)
Dec 2024
-194.63%(-24.4%)
-138.80%(+20.0%)
Sep 2024
-
-173.44%(+10.9%)
Jun 2024
-
-194.60%(+27.1%)
Mar 2024
-
-266.86%(+17.1%)
Dec 2023
-156.45%(-37.5%)
-322.07%(-102.4%)
Sep 2023
-
-159.09%(-13.4%)
Jun 2023
-
-140.25%(-15.7%)
Mar 2023
-
-121.20%(-2.5%)
Dec 2022
-113.81%
-118.20%(-24.2%)
Sep 2022
-
-95.16%(-22.0%)
DateAnnualQuarterly
Jun 2022
-
-77.99%(-15.0%)
Mar 2022
-
-67.82%(-33.3%)
Dec 2021
-55.20%(+91.2%)
-50.88%(+29.2%)
Sep 2021
-
-71.91%(+24.4%)
Jun 2021
-
-95.15%(+49.8%)
Mar 2021
-
-189.68%(+95.2%)
Dec 2020
-624.22%(-2229.7%)
-3981.47%(-7392.1%)
Sep 2020
-
54.60%(-10.8%)
Jun 2020
-
61.21%(+302.7%)
Mar 2020
-
15.20%(+97.9%)
Dec 2019
29.31%(-5.8%)
7.68%
Dec 2018
31.12%
-

FAQ

  • What is Immunome, Inc. annual return on equity?
  • What is the all-time high annual ROE for Immunome, Inc.?
  • What is Immunome, Inc. annual ROE year-on-year change?
  • What is Immunome, Inc. quarterly return on equity?
  • What is the all-time high quarterly ROE for Immunome, Inc.?
  • What is Immunome, Inc. quarterly ROE year-on-year change?

What is Immunome, Inc. annual return on equity?

The current annual ROE of IMNM is -194.63%

What is the all-time high annual ROE for Immunome, Inc.?

Immunome, Inc. all-time high annual return on equity is 31.12%

What is Immunome, Inc. annual ROE year-on-year change?

Over the past year, IMNM annual return on equity has changed by -38.18% (-24.40%)

What is Immunome, Inc. quarterly return on equity?

The current quarterly ROE of IMNM is -86.60%

What is the all-time high quarterly ROE for Immunome, Inc.?

Immunome, Inc. all-time high quarterly return on equity is 61.21%

What is Immunome, Inc. quarterly ROE year-on-year change?

Over the past year, IMNM quarterly return on equity has changed by +108.00% (+55.50%)
On this page